Zedoresertib and lunresertib combination shows promising antitumor activity (IMAGE)
Caption
Timothy Yap, M.B.B.S., Ph.D.
Credit
The University of Texas MD Anderson Cancer Center
Usage Restrictions
Restricted to one-time use by The University of Texas MD Anderson Cancer Center
License
Original content